8.93

12.37% -1.26

After Hours: 8.73 -0.20 -2.24%

Zynex Inc (ZYXI)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Zynex Inc stock is traded at $8.93, with a volume of 1.03M. It is down -12.37% in the last 24 hours and up +0.00% over the past month. Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

Previous Close:

$10.19

Open:

$8.1

24h Volume:

1.03M

Market Cap:

$283.75M

Revenue:

$184.32M

Net Income/Loss:

$9.73M

P/E Ratio:

19.41

EPS:

0.46

Net Cash Flow:

$16.55M

1W Performance:

-11.58%

1M Performance:

+0.00%

6M Performance:

-21.60%

1Y Performance:

-6.69%

1D Range:

$7.81

$8.97

52W Range:

$6.88

$13.77

Zynex Inc Stock (ZYXI) Company Profile

Name

Zynex Inc

Sector

Healthcare (1186)

Industry

Medical Distribution (11)

Phone

(800)-495-6670

Address

9655 MAROON CIRCLE, ENGLEWOOD, CO

Employee

1,101

Twitter

@zynexmedical

Next Earnings Date

2024-07-25

Latest SEC Filings

ZYXI's Discussions on Twitter

Zynex Inc Stock (ZYXI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-06-23	Upgrade	Piper Sandler	Neutral → Overweight
Feb-28-22	Reiterated	B. Riley Securities	Buy
Jul-16-21	Upgrade	B. Riley Securities	Neutral → Buy
Mar-09-21	Upgrade	Northland Capital	Market Perform → Outperform
Feb-26-21	Downgrade	B. Riley Securities	Buy → Neutral
Jan-29-21	Downgrade	Piper Sandler	Overweight → Neutral
Jan-28-21	Downgrade	Northland Capital	Outperform → Market Perform
Sep-14-20	Upgrade	H.C. Wainwright	Neutral → Buy
Sep-09-20	Upgrade	Northland Capital	Market Perform → Outperform
Jul-29-20	Upgrade	B. Riley FBR	Neutral → Buy
Jul-20-20	Initiated	Piper Sandler	Overweight
Jul-13-20	Downgrade	B. Riley FBR	Buy → Neutral
Jul-10-20	Reiterated	H.C. Wainwright	Neutral
Jun-16-20	Downgrade	Northland Capital	Outperform → Market Perform
May-19-20	Downgrade	H.C. Wainwright	Buy → Neutral
Apr-01-20	Initiated	Northland Capital	Outperform
Sep-23-19	Initiated	H.C. Wainwright	Buy